Home › Therapeutic areas › Oncology › Neuroendocrine Tumors
Neuroendocrine Tumors (2 companies)
Companies with an active program in Neuroendocrine Tumors.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | MetabolicOncology Rare | 2 | Approved | 7 |
| CATX | Perspective Therapeutics, Inc. | Oncology | 1 | Phase 1 | 3 |
No companies match.